Product Image

Acetyl L-Carnitine 500 mg

Carlson
4.8
★ ★ ★ ★ ★
(402 ratings)
Acetyl L-Carnitine 500 mg
Product Image
Score85
A practical single-ingredient ALCAR HCl capsule with a useful amount and many servings. Form disclosure is good, while sourcing detail is limited.
How scoring works
Quantity:120 Capsule(s) • (120 servings)
Goals:
Anti-Aging
Brain Health
Mental Focus
Productivity Boost
Cognitive Support
Metabolism Boost
Weight Loss
Energy

Score 85

A practical single-ingredient ALCAR HCl capsule with a useful amount and many servings. Form disclosure is good, while sourcing detail is limited.
How scoring works
$38.25($0.31 per serving)
Pure Formulas
$ 38.25
iHerb
$ 38.25
Report prices

Analysis

The acetylated form and hydrochloride salt are both disclosed, and the amount reaches a useful starting range. The single-active design makes total intake easy to track.

ALCAR may be most relevant for mental fatigue or mitochondrial energy support. Its evidence is less direct for weight loss and it does not provide an acute stimulant effect.

A large bottle lowers reorder frequency for established users. Buyers wanting stronger disclosure will need branded raw-material or independent-testing information not supplied here.

Who is it for
  • Adults seeking focused ALCAR support
  • Regular users who prefer larger bottles
Best for
  • Brain-energy routines
  • Stimulant-free cellular support

Pros

  • Clearly named ALCAR HCl
  • Useful targeted amount
  • Large serving count

Cons

  • No branded source
  • No purity evidence supplied
  • Narrow pathway coverage

Warnings

  • May cause digestive upset or restlessness
  • Use earlier in the day if sleep is affected
  • Discuss use with thyroid or seizure medications

Nutrient quality

94 Highest impact

A specific acetyl-L-carnitine salt and meaningful amount support the intended energy and cognitive uses. The focused formula avoids obvious filler or excessive dosing.

.

Ingredient transparency

83 Highest impact

The active form and amount are disclosed clearly without a hidden blend. Daily-use directions and non-active ingredients are not supplied.

.

Customer satisfaction

66 High impact

The available rating is strong and the sample is moderate. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

94 Highest impact

A meaningful focused amount and strong supply deliver strong practical value. No unnecessary active extras inflate the formula.

.
Report analysis

Goals

Anti-Aging
Impact
Highest effect
B+ Goal FitA- Strength of SupportC CoverageA+ Formula Quality

Acetyl L-carnitine directly supports mitochondrial energy and neurological function. The named hydrochloride form and meaningful amount make the active easy to evaluate.

Human evidence is useful for selected cognitive and fatigue outcomes, but it does not establish comprehensive anti-aging benefits. The single-ingredient design delivers depth without covering structural, vascular, inflammatory, or glycation-related pathways.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Brain Health
Impact
Highest effect
B+ Goal FitB+ Strength of SupportC- CoverageA+ Formula Quality

Acetyl L-carnitine supports mitochondrial energy and acetylcholine-related function in the brain. The 500 mg amount is a useful starting serving, although many clinical uses employ a larger daily total.

The HCl form and exact amount are clearly disclosed in a focused single-active capsule. Coverage remains narrow because the formula does not include membrane lipids, adaptogens, or other neurotransmitter precursors.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Mental Focus
Impact
High effect
B Goal FitA- Strength of SupportC CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl-L-carnitine supports brain energy metabolism and acetyl-group availability, giving it a direct mental-stamina role. Its effect is focused rather than a complete attention stack.

The 500 mg ALCAR HCl amount is clearly disclosed and reaches a practical target. Branded sourcing and purity-testing details are not supplied.

Study evidence
Acetyl L-Carnitine Supportive 7 studies
Productivity Boost
Impact
High effect
B Goal FitA- Strength of SupportC CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mgAcetyl L-Carnitine · 500 mg

Acetyl-L-carnitine supports cerebral energy metabolism and acetyl-group availability, giving it a direct mental-stamina role. Its productivity contribution is focused rather than comprehensive.

The 500 mg ALCAR HCl amount is fully disclosed and reaches a practical target. Branded sourcing and purity-testing details are not supplied.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Acetyl L-Carnitine Supportive 1 study
Cognitive Support
Impact
High effect
B Goal FitB+ Strength of SupportC- CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl-L-carnitine supports mitochondrial energy and can provide acetyl groups used in acetylcholine production. Human cognitive evidence is more consistent in aging or impaired populations than in healthy adults.

The hydrochloride form and exact amount are clearly disclosed in a focused capsule. The serving provides moderate depth without unrelated ingredients, but it does not address circulation or stress-related cognitive fatigue.

Study evidence
Acetyl L-Carnitine Supportive 20 studies
Metabolism Boost
Impact
High effect
B+ Goal FitB Strength of SupportC- CoverageA Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine directly supports mitochondrial fatty-acid transport and cellular energy production. The bioavailable form is clearly disclosed, though the amount is at the lower edge of many purpose-specific supplemental regimens.

The formula is highly focused and free from padding. It provides one relevant mitochondrial pathway without thermogenic, thyroid, or glycemic-control coverage.

Study evidence
Acetyl L-Carnitine Adverse 1 study

Ingredients

IngredientAmount per serving
Acetyl L-Carnitine (Acetyl L-Carnitine HCl)
500 mg
Gluten Free Adults 18–50 Women
Report overview
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB Value

The formula uses only acetyl L-carnitine in a clearly identified hydrochloride form. Its disclosed dose falls within the preferred range, but no branded sourcing or purity-testing detail is provided. The cost per effective amount is moderate rather than exceptional.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsCognitive Support Brain Health forAcetyl L-Carnitine
  2. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  4. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.
    Brooks JO; Yesavage JA; Carta A; Bravi D · International psychogeriatrics · 1998
    Randomized trial334 participantsCognitive Support forAcetyl L-Carnitine
  5. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.
    Thal LJ; Calvani M; Amato A; Carta A · Neurology · 2000
    Randomized trial229 participantsCognitive Support forAcetyl L-Carnitine
  6. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
    Rai G; Wright G; Scott L; Beston B; Rest J; Exton-Smith AN · Current medical research and opinion · 1990
    Randomized trial36 participantsBrain Health forAcetyl L-Carnitine
  7. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S · The Cochrane database of systematic reviews · 2012
    Systematic review1 studies pooledEnergy forAcetyl L-Carnitine
  8. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D · International journal of clinical pharmacology research · 1989
    Randomized trial30 participantsBrain Health forAcetyl L-Carnitine
  9. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
    Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S · Clinical and experimental rheumatology · 2007
    Randomized trial102 participantsEnergy forAcetyl L-Carnitine
  10. The Effect of Acylcarnitines on Cognitive Function: A Two-Sample Mendelian Randomization Study.
    Luan S; Zhang J; Wang C; Wang Z; Zhou J · Brain and behavior · 2025
    OtherBrain Health forAcetyl L-Carnitine
  11. Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
    Montanari S; Jansen R; Schranner D; Kastenmüller G; Arnold M; Janiri D; Sani G; Bhattacharyya S; Mahmoudian Dehkordi S; Dunlop BW; Rush AJ; Penninx BWHJ; Kaddurah-Daouk R; Milaneschi Y · Translational psychiatry · 2025
    Cohort study2,574 participantsEnergy forAcetyl L-Carnitine
  12. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsAnti-Aging forAcetyl L-Carnitine
  13. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  14. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  15. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  16. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  17. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  18. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  19. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  20. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  21. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  22. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  23. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  24. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  25. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  26. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.
    Krims-Davis K; Ozola M; Razzivina V; Gukalova B; Konrade I; Dambrova M; Liepinsh E · Molecular nutrition & food research · 2025
    Randomized trialMetabolism Boost forAcetyl L-Carnitine